Companies / Abbott Laboratories / Activity
Activity — Abbott Laboratories
50 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Ford Robert B CEO | Other | Common shares without par value | $3.52M | -30K -9.00% | 306,461 0.02% of shares | low |
| Jan 23, 2026 | Ford Robert B CEO | Buy | Common shares without par value | $2.01M | +19K +9.52% | 216,203 0.01% of shares | high |
| Feb 27, 2026 | Earnhardt Lisa D Executive | Other | Common shares without par value | $997.2K | -9K -8.67% | 90,407 <0.01% of shares | low |
| Feb 27, 2026 | Boudreau Philip P Executive | Other | Common shares without par value | $865.1K | -7K -9.47% | 71,172 <0.01% of shares | low |
| Feb 27, 2026 | Salvadori Daniel Gesua Sive Executive | Other | Common shares without par value | $769.1K | -7K -4.30% | 147,262 <0.01% of shares | low |
| Feb 27, 2026 | Scoggins Christopher J Executive | Other | Common shares without par value | $581.0K | -5K -6.08% | 77,126 <0.01% of shares | low |
| Feb 4, 2026 | Starks Daniel J Director | Buy | Common shares without par value | $545.2K | +5K +0.07% | 6,738,817 0.39% of shares | high |
| Feb 4, 2026 | Starks Daniel J Director | Buy | Common shares without par value | $542.1K | +5K +0.07% | 6,733,784 0.39% of shares | high |
| Feb 27, 2026 | Moreland Mary K Executive | Other | Common shares without par value | $538.3K | -5K -4.23% | 104,904 <0.01% of shares | low |
| Feb 27, 2026 | Morrone Louis H. Executive | Other | Common shares without par value | $469.7K | -4K -4.93% | 77,987 <0.01% of shares | low |
| May 7, 2026 | Stratton John G Director | Buy | Common shares without par value | $173.6K | +2K +9.38% | 23,319 <0.01% of shares | medium |
| Feb 27, 2026 | Cushman Elizabeth C. Executive | Other | Common shares without par value | $165.2K | -1K -3.53% | 38,836 <0.01% of shares | low |
| Feb 27, 2026 | Shroff Eric Executive | Other | Common shares without par value | $160.9K | -1K -3.35% | 39,873 <0.01% of shares | low |
| Feb 27, 2026 | McCoy John a. Jr. Executive | Other | Common shares without par value | $132.8K | -1K -4.33% | 25,213 <0.01% of shares | low |
| Mar 2, 2026 | Morrone Louis H. Executive | Sell | Common shares without par value | $132.2K | -1K -1.47% | 76,843 <0.01% of shares | medium |
| Mar 2, 2026 | Salvadori Daniel Gesua Sive Executive | Sell | Common shares without par value | $102.3K | -885 -0.60% | 146,377 <0.01% of shares | medium |
| Mar 2, 2026 | Shroff Eric Executive | Sell | Common shares without par value | $81.9K | -709 -1.78% | 39,164 <0.01% of shares | low |
| Mar 2, 2026 | Moreland Mary K Executive | Sell | Common shares without par value | $70.9K | -613 -0.58% | 104,291 <0.01% of shares | low |
| Mar 2, 2026 | McCoy John a. Jr. Executive | Sell | Common shares without par value | $67.6K | -585 -2.32% | 24,628 <0.01% of shares | low |
| Mar 2, 2026 | Cushman Elizabeth C. Executive | Sell | Common shares without par value | $30.4K | -263 -0.68% | 38,573 <0.01% of shares | low |
| Apr 24, 2026 | Stratton John G Director | Grant | Common shares without par value | $0 | +2K +12.01% | 21,319 <0.01% of shares | low |
| Apr 24, 2026 | Conroy Kevin T Director | Grant | Common shares without par value | $0 | +2K +1.74% | 133,737 <0.01% of shares | low |
| Apr 24, 2026 | McKinstry Nancy Director | Grant | Common shares without par value | $0 | +2K +5.90% | 41,010 <0.01% of shares | low |
| Feb 24, 2026 | Boudreau Philip P Executive | Grant | Common shares without par value | $0 | +28K +55.31% | 78,613 <0.01% of shares | low |
| Mar 23, 2026 | Orville Jacob a Executive | Grant | Common shares without par value | $0 | +13K +35.60% | 50,493 <0.01% of shares | low |
| Feb 24, 2026 | Cushman Elizabeth C. Executive | Grant | Common shares without par value | $0 | +15K +59.59% | 40,257 <0.01% of shares | low |
| Feb 24, 2026 | Shroff Eric Executive | Grant | Common shares without par value | $0 | +11K +35.79% | 41,257 <0.01% of shares | low |
| Feb 24, 2026 | Morrone Louis H. Executive | Grant | Common shares without par value | $0 | +15K +23.15% | 82,027 <0.01% of shares | low |
| Feb 24, 2026 | Moreland Mary K Executive | Grant | Common shares without par value | $0 | +14K +14.60% | 109,534 <0.01% of shares | low |
| Feb 24, 2026 | Scoggins Christopher J Executive | Grant | Common shares without par value | $0 | +19K +29.08% | 82,123 <0.01% of shares | low |
| Feb 24, 2026 | McCoy John a. Jr. Executive | Grant | Common shares without par value | $0 | +5K +25.61% | 26,355 <0.01% of shares | low |
| Feb 24, 2026 | Salvadori Daniel Gesua Sive Executive | Grant | Common shares without par value | $0 | +22K +16.37% | 153,877 <0.01% of shares | low |
| Feb 24, 2026 | Ford Robert B CEO | Grant | Common shares without par value | $0 | +83K +32.95% | 336,769 0.02% of shares | low |
| Feb 24, 2026 | Earnhardt Lisa D Executive | Grant | Common shares without par value | $0 | +27K +37.62% | 98,984 <0.01% of shares | low |
| Mar 31, 2026 | Stratton John G Director | Grant | Stock Equivalent Units | — | +382 +2.91% | 13,489 <0.01% of shares | low |
| Apr 24, 2026 | McKinstry Nancy Director | Grant | Option (right to buy) | — | +2K | 2,305 <0.01% of shares | low |
| Feb 24, 2026 | Boudreau Philip P Executive | Grant | Option (right to buy) | — | +115K | 115,413 <0.01% of shares | low |
| Feb 24, 2026 | Cushman Elizabeth C. Executive | Grant | Option (right to buy) | — | +62K | 61,964 <0.01% of shares | low |
| Feb 24, 2026 | Shroff Eric Executive | Grant | Option (right to buy) | — | +45K | 44,821 <0.01% of shares | low |
| Feb 24, 2026 | Morrone Louis H. Executive | Grant | Option (right to buy) | — | +64K | 63,561 <0.01% of shares | low |
| Feb 24, 2026 | Moreland Mary K Executive | Grant | Option (right to buy) | — | +58K | 57,512 <0.01% of shares | low |
| Feb 24, 2026 | Scoggins Christopher J Executive | Grant | Option (right to buy) | — | +76K | 76,273 <0.01% of shares | low |
| Feb 24, 2026 | McCoy John a. Jr. Executive | Grant | Option (right to buy) | — | +22K | 22,151 <0.01% of shares | low |
| Feb 24, 2026 | Salvadori Daniel Gesua Sive Executive | Grant | Option (right to buy) | — | +89K | 89,226 <0.01% of shares | low |
| Feb 24, 2026 | Ford Robert B CEO | Grant | Option (right to buy) | — | +344K | 344,066 0.02% of shares | low |
| Feb 24, 2026 | Earnhardt Lisa D Executive | Grant | Option (right to buy) | — | +112K | 111,533 <0.01% of shares | low |
| Dec 31, 2025 | Gonzalez Patricia Paola Director | Grant | Stock Equivalent Units | — | +263 +5.32% | 5,208 <0.01% of shares | low |
| Dec 31, 2025 | Roman Michael F Director | Grant | Stock Equivalent Units | — | +301 +5.39% | 5,882 <0.01% of shares | low |
| Dec 31, 2025 | Alpern Robert J Director | Grant | Stock Equivalent Units | — | +62 +0.60% | 10,409 <0.01% of shares | low |
| Dec 31, 2025 | Stratton John G Director | Grant | Stock Equivalent Units | — | +313 +2.46% | 13,034 <0.01% of shares | low |